A systematic review to summarise current evidence about the role of LHRH agonists in the adjuvant treatment of ER+ early breast cancer in pre-menopausal women, with a view to providing evidence to support the information needs of women with breast cancer, clinicians, media and policy makers.
This resource has been superseded in-full or in-part by Review Use of taxanes for neo and adjuvant treatment early and locally advanced breast cancer.
File name: | lha-1-use-of-luteinising-ho...juvant-treatment-of-ebc.pdf |
File size: | 399.83 KB |
Cancer Type: | Breast cancer |
Publication Audience: | Resources for health professionals |
Year: | 2003 |
Document Status: | Greater than 5 years This resource was developed, reviewed or revised more than 5 years ago and may no longer reflect current evidence or best practice. |